A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

An Open-Label, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) With Adjunctive Xalatan® Eye Drops in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)

The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.

Inclusion Criteria:

• Over 18 years
• Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension
• Currently on prostaglandin therapy

Exclusion Criteria:

• Uncontrolled medical conditions
• Subjects who wear contact lenses
• Subjects requiring chronic topical artificial tears, lubricants, and /or - requiring any other chronic topical medications